Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label study designed to evaluate the effect of renal disease on the
pharmacokinetics of vepoloxamer relative to the pharmacokinetics in healthy subjects with
normal renal function.